HOT TOPICS
SupplySide
The Benninger Blog
 |
Jon Benninger is the vice president of business development for the Health & Nutrition Network at VIRGO. He works on new products, international efforts, industry outreach and advocacy, content development, partnerships and collaborations, and strategic planning. Jon volunteers for many industry associations, committees and initiatives, is a frequent speaker and moderator at industry events, and assists VIRGO clients with solutions and strategies.. He joined VIRGO in 1995 and has served as editor, publisher, and group publisher prior to his current position. He earned a degree in journalism at Arizona State University. |
FDA Watching Claims on Facebook
Posted in
Blog,
Advertising Claims,
Food and Drug Administration (FDA),
Federal Trade Commission (FTC)
According to The Hill, FDA is cracking down on claims being made by drug companies on Facebook. The agency recently sent a letter to Novartis questioning its us of the "Share" application on Facebook. The agency objected to the presence of claims about benefits of the Novartis drug Tasigna that did not also include the side effect and risk information the drug makers must include in all marketing. Here is a link to the article on The Hill's website. And here is a more detailed article about the issue from Fox Business.
Regulators are taking more interest in online marketing activities beyond a company's basic website. This includes claims made on social media sites like Facebook, Linked In, Twitter, etc. Click here for a good article on how businesses and marketers can be sure their social media efforts do not get them in trouble with the FTC.
Comments
- Comments
Latest Articles
Subscribe to
Mobile Media Snaps
Get the latest media snap
Daniel Fabricant, Ph.D. talks about the New Dietary Ingredient (NDI) Draft Guidance released by FDA.